ESC 365 - Is ARB/CCB combination superior to ARB/HCTZ combination in day-by-day blood pressure variability reduction? a prospective randomized trial

ESC Premium Access

Is ARB/CCB combination superior to ARB/HCTZ combination in day-by-day blood pressure variability reduction? a prospective randomized trial

Session: Poster session 1 - Treatment of hypertension

Topic: Treatment of hypertension

Speaker: Professor H. Kai (Kurume, JP)

Event: ESC Congress 2016

Congress Presentation

Add to my library

About the speaker

Professor Hisashi Kai

Kurume University Medical Center, Kurume (Japan)

0 follower

10 more presentations in this session

A novel approach to perform renal sympathetic denervation in moderate to severe chronic kidney disease using carbon dioxide angiography

Speaker: Doctor M. Hameed (Birmingham, GB)

Results from real-world evidence and randomized controlled clinical studies with the combination of amlodipine and valsartan

Speaker: Doctor P. Brunel (Basel, CH)

Statins and perindopril\amlodipine efficacy in hypertensive patients with hypercholesterolemia

Speaker: Professor G. Radchenko (Kiev, UA)

Poor control of blood pressure is associated with increased risk of cardiovascular events in hypertensive patients with atherosclerotic vascular diseases, especially in the elderly

Speaker: Associate Professor W. Chang (Taipei, TW)

Factors that exacerbate resistance to the antihypertensive treatment in hypertensive patients with diabetes

Speaker: Professor Y. Dohi (Nagoya, JP)

Access the full session

Poster session 1 - Treatment of hypertension

Speakers: Professor H. Kai, Doctor M. Hameed, Doctor P. Brunel, Professor G. Radchenko, Associate Professor W. Chang...

About the event

ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources